REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Bitres Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Information | Publishing Industries (except Internet) | Computer Systems Design and Related Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Research and Development in the Social Sciences and Humanities | All Other Professional, Scientific, and Technical Services
Full name: Bitres Sp. z o.o. Profile Updated: May 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Bitres Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was first established on September 13, 2019. The latest financial highlights indicate a net sales revenue increase of 42.92% in 2023. There was a total growth of 2.95% in Bitres Sp. z o.o.’s total assets over the same period. Bitres Sp. z o.o.’s net profit margin decreased by 23.02% in 2023.

Headquarters
Ul. Tytusa Chalubinskiego 9/2
Warsaw; Mazowieckie; Postal Code: 02-004

Contact Details: Purchase the Bitres Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Bitres Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bitres Sp. z o.o. report to view the information.
Incorporation Date:
September 13, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Bitres Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
42.92%▲
Total operating revenue
42.92%▲
Operating profit (EBIT)
-77.73%▼
Net Profit (Loss) for the Period
-79%▼
Total assets
2.95%▲
Total equity
3.19%▲
Operating Profit Margin (ROS)
-26.98%▼
Net Profit Margin
-23.02%▼
Return on Equity (ROE)
-12.09%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Aperto Sp. z o.o.
 
Kahle Sp. z o.o.
Frontline Biosciences S.A.
 
Nanolab Sp. z o.o.
Upgrow Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo